{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:37:41Z","timestamp":1777311461998,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    We report a case where\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA PET\/CT distinguished \u201cpseudo-progression\u201d from progression observed on\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA PET\/CT. In a 75-year-old man with metastatic castration-resistant prostate cancer (mCRPC),\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA PET\/CT revealed markedly increased tracer uptake in bone metastases compared with pretreatment imaging, suggesting radiologic progression. However,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA-11 PET\/CT images demonstrated the complete metabolic response (PERCIST 1.0), revealing \u201cpseudo-progression\u201d of bone lesions in\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA, especially when combined with clinical symptoms, PSA, and ALP levels.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006085","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:00:11Z","timestamp":1754413211000},"page":"87-89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["68Ga-PSMA PET\/CT Identifies \u201cPseudo-progression\u201d of Bone Lesions in Prostate Cancer Observed on 68Ga-DOTA-IBA PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"given":"Dong","family":"Huang","sequence":"first","affiliation":[{"name":"Departments of Nuclear Medicine, The First People\u2019s Hospital of Mianyang, Sichuan Mianyang 404 Hospital, Mianyang"},{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Jiangyang, Luzhou, Sichuan, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Jiangyang, Luzhou, Sichuan, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangjing","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Jiangyang, Luzhou, Sichuan, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Gong","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine, The First People\u2019s Hospital of Mianyang, Sichuan Mianyang 404 Hospital, Mianyang"},{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Jiangyang, Luzhou, Sichuan, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation"},{"name":"Institute of Nuclear Medicine, Southwest Medical University, Jiangyang, Luzhou, Sichuan, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/RLU.0b013e318286c148","article-title":"Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET","volume":"38","author":"Oborski","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s00259-019-04328-1","article-title":"Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment","volume":"46","author":"Costa","year":"2019","journal-title":"Eur J Nucl Med Mol I"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acs.molpharmaceut.2c00978","article-title":"Lutetium177-labeled DOTA-ibandronate: a novel radiopharmaceutical for targeted treatment of bone metastases","volume":"20","author":"Wang","year":"2023","journal-title":"Mol Pharmaceutics"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"1027792","DOI":"10.3389\/fonc.2022.1027792","article-title":"Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/RLU.0000000000004717","article-title":"177Lu-DOTA-IBA therapy in prostate cancer with bone metastases","volume":"48","author":"Li","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"1428498","DOI":"10.3389\/fonc.2024.1428498","article-title":"Prospective comparison of 68Ga-DOTA-ibandronate and bone scans for detecting bone metastases in breast cancer","volume":"14","author":"Xiang","year":"2024","journal-title":"Front Oncol"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/RLU.0000000000005010","article-title":"177Lu-PSMA-617 therapy in a case of metastatic castration-resistant prostate cancer","volume":"49","author":"Qu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2967\/jnumed.119.240242","article-title":"Early prostate-specific antigen changes and clinical outcome after 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer","volume":"61","author":"Gafita","year":"2020","journal-title":"J Nucl Med"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1097\/RLU.0000000000004222","article-title":"Outcome of 177Lu-PSMA radionuclide treatment in advanced prostate cancer and its association with clinical parameters: a single-center experience","volume":"47","author":"Has Simsek","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/RLU.0000000000005303","article-title":"Flare phenomenon after 177Lu-DOTA-IBA therapy in bone metastases of lung cancer","volume":"49","author":"Hua","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:01:28Z","timestamp":1765371688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006085","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"2025-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}